Triptorelin is a potent synthetic GnRH agonist with well-established clinical applications. Its biphasic action — initial stimulation followed by sustained suppression — makes it useful in both activating and suppressing reproductive hormones depending on the protocol.
Research Applications
Gonadotropin modulation, hormone-dependent condition research, fertility protocols, and HPG axis reset studies.
Dosage Information (Research Use)
Single low-dose research use: 50-100 mcg as a single subcutaneous injection. Chronic use causes sustained suppression. Potent compound — research use only.
Reconstitution & Handling
Standard BAC water reconstitution. Very potent — precise dosing critical.
Half-Life & Pharmacokinetics
Approximately 7.6 hours.
Reported Observations in Literature
Initial testosterone/estrogen flare, followed by sustained suppression. Hot flashes, mood changes, bone density concerns with chronic use.
Key Research References
- Huirne JA, Lambalk CB. “Gonadotropin-releasing-hormone-receptor antagonists.” Lancet. 2001